Navigation Links
Viral Genetics Completes Second Major Debt Conversion
Date:8/26/2009

nd indicate "Viral Genetics" as the source.

ABOUT VIRAL GENETICS, INC.:

Viral Genetics, Inc. is a biotechnology company that discovers and develops immune-based therapies for HIV, AIDS and other autoimmune diseases using its thymus nuclear protein compound (TNP). The company recently entered into an Exclusive License Agreement with the University of Colorado and V-Clip Pharmaceuticals (a subsidiary of the Company) to license technology developed by M. Karen Newell, PhD, that appears to explain TNP and provide a means to optimize therapies based on TNP for future clinical trials. Viral Genetics believes that its investigational HIV/AIDS drug based on TNP, called VGV-1, represents a unique approach to treating HIV due to the apparently novel mechanism, low toxicity profile, simple dosing regimen, and short-course of treatment. As a type of immune-based therapy, it focuses on boosting the immune system to allow the body to fight HIV more efficiently. VGV-1 has been studied in five human clinical trials for the treatment of HIV/AIDS. Online at www.viralgenetics.com

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports filed with the SEC. VGV-1 is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Viral Genetics believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurat
'/>"/>

SOURCE Viral Genetics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
2. MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes
3. Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement
4. HIV integrase inhibitor effective for patients beginning antiretroviral treatment
5. Earlier HIV antiviral treatment can be cost effective in areas of limited resources
6. Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells
7. Vaporized viral vector shows promise in anti-cancer gene therapy
8. MicroRNA regulation of tumor-killing viruses avoids unwanted viral pathology
9. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
10. CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
11. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Charlotte, NC (PRWEB) May 21, 2015 ... regulates the surface temperature of each side of the ... With ChiliPad, users on either side of the bed ... all night, helping them fall asleep faster and stay ... patented system with water to regulate the temperature which ...
(Date:5/21/2015)... New York, New York (PRWEB) May 21, 2015 ... of The Atmananda Yoga Studio and Sequence, is ... popular Atmananda Yoga Mat™, which was previously available for ... The Atmananda Yoga Mat™ unique is that it's ... help prevent serious joint injuries and muscle strains, ...
(Date:5/21/2015)... Mich. (PRWEB) May 21, 2015 Many ... opposite effect on those with celiac disease according to ... than half of the probiotics tested in the study ... foods and dietary supplements and cause gastrointestinal inflammation for ... Companies aiming to gain consumer trust in gluten-free claims ...
(Date:5/21/2015)... Neogenis Labs , a world leader ... been named to the 2015 Austin A-List by the Austin ... by Southwest Interactive. , The A-List companies , selected ... nominations, were officially revealed and named to the annual Austin ... ACL-Live. The 12 honorees for 2015 were named in three ...
(Date:5/21/2015)... New York (PRWEB) May 21, 2015 ... Roslin, MD, Director of Bariatric Surgery at Northern Westchester ... bariatric surgery procedure called Stomach Intestinal Pylorus-Sparing Surgery ... modification to the duodenal switch procedure and benefits patients ... , The Stomach Intestinal Pylorus-Sparing Surgery technique was broadcast ...
Breaking Medicine News(10 mins):Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 2Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 3Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 2Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 3
... , VISTA, Calif., Aug. 6 Nutritional ... a new marketing campaign touting its flagship, patented nutritional supplement product ... , , The new marketing campaign takes a ... drink enhancer by using a caricature of Albert Einstein at a ...
... , , OLDSMAR, Fla., ... of the largest and most established leaders in stem cell innovation, ... in menstrual blood (known as MenSCs) during the Fourth China Medical ... vitro study show that MenSCs proliferate rapidly and have significant potential ...
... , ( ) , , , ... N.J., Aug. 6 Smart Balance, Inc. (Nasdaq: SMBL ) today announced its ... of $58.2 million, an increase of 21.2% versus year ago, and earnings per share of ... The second quarter net sales increase versus 2008 was due to a 13% ...
... U.S. adults unaware there is no cure, survey finds , ... U.S. adults mistakenly believe that daily medicine can be taken ... that found a widespread lack of knowledge and awareness about ... of 2,148 adults also found that nearly half of respondents ...
... are choosing it for their animal companions , THURSDAY, Aug. ... anymore, as more animal owners are making that choice for ... , For nearly 20 years, a handful of veterinarians has ... kidney failure, to die peacefully at home, not in a ...
... , NASHVILLE, Tenn. and GLEN ... find that 76 percent of surveyed pharmacy directors say ... will have only one preferred biologic for all immune ... ulcerative colitis. According to the new Formulary Forum report ...
Cached Medicine News:Health News:Global Health Trax, Inc. Announces New Marketing Campaign for Oxygen Elements Max Product 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 2Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 3Health News:Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 4Health News:Smart Balance Announces 2009 Second Quarter Results 2Health News:Smart Balance Announces 2009 Second Quarter Results 3Health News:Smart Balance Announces 2009 Second Quarter Results 4Health News:Smart Balance Announces 2009 Second Quarter Results 5Health News:Smart Balance Announces 2009 Second Quarter Results 6Health News:Smart Balance Announces 2009 Second Quarter Results 7Health News:Smart Balance Announces 2009 Second Quarter Results 8Health News:Smart Balance Announces 2009 Second Quarter Results 9Health News:Smart Balance Announces 2009 Second Quarter Results 10Health News:Food Allergy Facts Need More Focus 2Health News:Hospice Care Eases the End for Loyal Pets 2Health News:Hospice Care Eases the End for Loyal Pets 3Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 2Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 3
(Date:5/21/2015)... CHICAGO, Ill. , May 21, 2015  AbbVie ... offer consideration amounts pursuant to its previously announced offer ... Pharmacyclics, Inc. ("Pharmacyclics") for a mix of cash and ... on Form S-4 filed with the Securities and Exchange ... Based on the assumption that the exchange offer will ...
(Date:5/21/2015)... , May 21, 2015 Omnicell, ... general availability of its Unity enterprise platform, the premier ... wide range of patient care venues throughout hospitals and ... enhanced interoperability between the Epic electronic health record (EHR) ... to meet the needs of health care providers. Through ...
(Date:5/21/2015)... 21 mai 2015 Dipexium Pharmaceuticals, Inc. ... stade avancé axée sur le développement ... pexiganan 0,8 %), et des collaborateurs de ... présentation d,affiches scientifiques présentant la conception ... 3 de la société pour l,évaluation ...
Breaking Medicine Technology:AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 2Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 3Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 4Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 2Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 3Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 4Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 5Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 6Dipexium annonce une présentation lors du 7e International Symposium on the Diabetic Foot 7
... MORRISTOWN, N.J. , July 12 ... confirmed that its subsidiary, Watson Laboratories, Inc., filed an ... and Drug Administration (FDA) seeking approval to market sevelamer ...  Watson,s sevelamer carbonate for oral suspension product is the ...
... BETHESDA, Md. , July 12 The Hanger ... generous donation of $75,000 from Grapes for Humanity/US, ... dollars in support of landmine survivors and innocent victims of ... used by the Hanger Ivan R. Sabel Foundation to continue ...
Cached Medicine Technology:Watson Confirms Renvela® for Oral Suspension Patent Challenge 2Watson Confirms Renvela® for Oral Suspension Patent Challenge 3Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US 2
... for Cardiology is the first digital solution ... modalities both within and outside cardiology. From ... the archival solutions, Agfas combined expertise in ... and their customers to work the way ...
Full Digital Ultrasound System...
... Nemio is engineered with the latest technologies ... enhance your clinical insight. These advancements increase ... crisp images that improve visualization of even ... connectivity, you can speed information delivery and ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Medicine Products: